V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002301 | 230006774 | 1.64 | 63.2 | null | 2018-10-06 | 2018-10-06 | ICON8B TRIAL | 02 | null | IPILIMUMAB + NIVOLUMAB | 101230651 |
| 230002302 | 230006775 | null | null | null | null | 2020-05-05 | null | null | null | GEMCITABINE | 101803124 |
| 230002303 | 230006776 | 1.54 | 73.6 | null | 2019-09-16 | 2019-09-30 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100434956 |
| 230002305 | 230006777 | 1.52 | 63.5 | null | 2018-08-16 | 2018-09-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100971822 |
| 230002306 | 230006778 | 1.55 | 101 | null | null | 2019-12-20 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100902029 |
| 230002307 | 230006779 | 1.59 | 58.9 | null | null | 2020-09-21 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101679970 |
| 230002309 | 230006780 | 1.61 | 72.2 | Adjuvant (A) | null | 2021-07-16 | Bevacizumab+Carbo+Pacliaxel | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101810486 |
| 230002313 | 230006782 | 1.58 | 73.1 | Palliative (P) | 2021-08-16 | 2021-08-17 | null | 02 | N | CYCLOPHOSPHAMIDE | 101541704 |
| 230002315 | 230006783 | null | null | null | null | 2021-08-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100647048 |
| 230002317 | 230006784 | 1.59 | 49.5 | null | 2019-09-01 | 2019-09-13 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100016451 |
| 230002321 | 230006788 | 1.64 | 91.5 | Palliative (P) | 2019-12-28 | 2020-03-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100046257 |
| 230002322 | 230006789 | 1.63 | 49.55 | Adjuvant (A) | 2012-08-19 | 2016-10-26 | Rucaparib | 02 | null | RUCAPARIB | 100733512 |
| 230002325 | 230006791 | 1.67 | 58 | null | 2020-05-05 | 2020-05-05 | Niraparib | 02 | null | NIRAPARIB | 101826407 |
| 230002327 | 230006792 | null | null | Curative (C) | 2017-02-10 | 2017-03-04 | null | null | N | CISPLATIN | 100739585 |
| 230002329 | 230006793 | 1.71 | 64.3 | Palliative (P) | null | 2019-03-29 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101395930 |
| 230002331 | 230006795 | 1.6 | 59.9 | null | 2016-09-21 | 2016-10-05 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101729418 |
| 230002334 | 230006797 | 1.54 | 69.6 | null | 2020-11-17 | 2020-11-26 | null | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100612079 |
| 230002335 | 230006798 | 1.61 | 89 | Palliative (P) | 2014-03-19 | 2016-11-14 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101572000 |
| 230002337 | 230006800 | 1.67 | 59.7 | Adjuvant (A) | null | 2019-09-08 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100935145 |
| 230002338 | 230006801 | 1.64 | 57.1 | null | 2019-09-07 | 2019-09-17 | Niraparib | 02 | null | TRIAL UNSPECIFIED | 100508491 |
| 230002341 | 230006803 | null | null | null | 2021-03-12 | 2021-03-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101105721 |
| 230002343 | 230006804 | null | null | null | 2021-07-29 | 2021-08-14 | null | 02 | null | CISPLATIN + DOXORUBICIN | 100055197 |
| 230002344 | 230006805 | null | null | Palliative (P) | null | 2018-12-11 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN | 100985732 |
| 230002345 | 230006806 | 1.57 | 72.9 | null | null | 2021-04-26 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100861950 |
| 230002346 | 230006807 | null | null | Palliative (P) | 2017-12-10 | 2017-12-10 | Gemcitabine day 1&8 | null | N | CARBOPLATIN | 101204510 |
| 230002349 | 230006808 | 1.66 | 75 | null | 2017-10-03 | 2017-10-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100379957 |
| 230002350 | 230006809 | 1.69 | null | null | 2021-10-27 | 2022-05-15 | ICON8B TRIAL | 02 | null | NIVOLUMAB | 100500638 |
| 230002351 | 230006810 | 1.59 | 71.2 | null | 2019-09-02 | 2019-09-09 | Olaparib | 02 | null | OLAPARIB | 100331322 |
| 230002352 | 230006811 | null | null | null | 2017-11-27 | 2017-12-11 | Bevacizumab+Carbo+Pacliaxel | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100003768 |
| 230002356 | 230006813 | 1.55 | 86.9 | null | null | 2022-03-13 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN | 101583335 |
| 230002358 | 230006814 | null | null | Palliative (P) | null | 2018-11-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101061102 |
| 230002359 | 230006815 | 1.59 | 69.6 | Palliative (P) | 2019-09-24 | 2019-10-04 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101386716 |
| 230002361 | 230006816 | 1.6 | 95.3 | null | 2021-03-20 | 2021-03-24 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100917838 |
| 230002362 | 230006817 | 1.68 | 54.2 | null | 2018-11-24 | 2021-03-23 | PACLITAXEL | 02 | null | PACLITAXEL | 100665034 |
| 230002363 | 230006818 | 1.62 | 71.3 | Palliative (P) | 2018-02-04 | 2018-02-04 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101705470 |
| 230002366 | 230006820 | null | null | null | 2020-04-13 | 2020-04-13 | GEMCITABINE | 02 | null | TRIAL UNSPECIFIED | 101050517 |
| 230002367 | 230006821 | 1.57 | 67.8 | Palliative (P) | 2020-05-02 | 2020-07-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100717441 |
| 230002368 | 230006822 | 1.7 | 110.25 | null | 2019-10-11 | 2019-10-11 | null | null | null | CYCLOPHOSPHAMIDE | 100273349 |
| 230002371 | 230006824 | 1.7 | 69.1 | null | 2020-03-08 | 2020-03-12 | Bevacizumab 7.5mg/kg | 02 | null | CISPLATIN + ETOPOSIDE | 101101881 |
| 230002372 | 230006825 | 1.63 | 67.7 | null | 2017-02-16 | 2017-03-10 | Olaparib | 02 | null | OLAPARIB | 100562230 |
| 230002373 | 230006826 | 1.59 | 67 | Curative (C) | 2019-03-09 | 2019-04-14 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101325375 |
| 230002378 | 230006828 | 1.65 | 70.3 | Palliative (P) | 2019-09-21 | 2020-12-25 | Paclitaxel (2 or 3 weekly) | 02 | N | PACLITAXEL | 100264048 |
| 230002381 | 230006829 | 1.66 | 92.8 | null | 2019-08-05 | 2019-08-06 | Bevacizumab | 02 | null | BEVACIZUMAB | 101382307 |
| 230002383 | 230006830 | 1.61 | 89 | Palliative (P) | 2020-03-28 | 2021-03-05 | PACLITAXEL | 02 | null | PACLITAXEL | 100262604 |
| 230002385 | 230006832 | null | null | Neo-adjuvant (N) | null | 2020-01-23 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101408135 |
| 230002386 | 230006833 | 1.61 | 52.4 | null | 2022-02-11 | 2022-03-04 | Rucaparib | 02 | null | RUCAPARIB | 101090814 |
| 230002390 | 230006836 | null | null | null | 2020-04-30 | 2020-07-11 | ICON8B TRIAL | 02 | null | CAPECITABINE + CARBOPLATIN | 100193772 |
| 230002391 | 230006837 | 1.63 | 69.8 | null | 2016-03-11 | 2016-03-11 | null | 02 | null | DOXORUBICIN | 101703031 |
| 230002392 | 230006838 | null | null | null | null | 2020-09-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101145028 |
| 230002393 | 230006839 | 1.52 | null | Palliative (P) | 2019-10-28 | 2020-02-05 | PACLITAXEL | 02 | N | PACLITAXEL | 100599014 |